2024. Experience of Using Stereotactic Ablative Radiotherapy for Radical Treatment of Low and Intermediate Risk Prostate Cancer. Voprosy onkologii. 70, 2 (May 2024), 292–298. DOI:https://doi.org/10.37469/0507-3758-2024-70-2-292-298.